Stanisic, S., Bertolotto, A., Berto, P., Di Procolo, P. and Morawski, J. (2019) “The cost-effectiveness of alemtuzumab in the management of relapse-remitting multiple sclerosis in Italy”, Global & Regional Health Technology Assessment, 6(1). doi: 10.33393/grhta.2019.465.